227 related articles for article (PubMed ID: 25072151)
1. Mycobacterium biofilms: factors involved in development, dispersal, and therapeutic strategies against biofilm-relevant pathogens.
Xiang X; Deng W; Liu M; Xie J
Crit Rev Eukaryot Gene Expr; 2014; 24(3):269-79. PubMed ID: 25072151
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial Biofilms: Revisiting Tuberculosis Bacilli in Extracellular Necrotizing Lesions.
Basaraba RJ; Ojha AK
Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28597824
[TBL] [Abstract][Full Text] [Related]
3. Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.
Sambandan D; Dao DN; Weinrick BC; Vilchèze C; Gurcha SS; Ojha A; Kremer L; Besra GS; Hatfull GF; Jacobs WR
mBio; 2013 May; 4(3):e00222-13. PubMed ID: 23653446
[TBL] [Abstract][Full Text] [Related]
4. Expression of Mycobacterium tuberculosis NLPC/p60 family protein Rv0024 induce biofilm formation and resistance against cell wall acting anti-tuberculosis drugs in Mycobacterium smegmatis.
Padhi A; Naik SK; Sengupta S; Ganguli G; Sonawane A
Microbes Infect; 2016 Apr; 18(4):224-36. PubMed ID: 26706821
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial biofilms: Understanding the genetic factors playing significant role in pathogenesis, resistance and diagnosis.
Patel RR; Arun PP; Singh SK; Singh M
Life Sci; 2024 Aug; 351():122778. PubMed ID: 38879157
[TBL] [Abstract][Full Text] [Related]
6. Identification of Anti-Mycobacterial Biofilm Agents Based on the 2-Aminoimidazole Scaffold.
Nguyen TV; Minrovic BM; Melander RJ; Melander C
ChemMedChem; 2019 May; 14(9):927-937. PubMed ID: 30834698
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
Chakraborty P; Kumar A
Microb Cell; 2019 Jan; 6(2):105-122. PubMed ID: 30740456
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of Mycobacterium tuberculosis to Biofilm Growth Is Genetically Linked to Drug Tolerance.
Richards JP; Cai W; Zill NA; Zhang W; Ojha AK
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501144
[No Abstract] [Full Text] [Related]
9. Bioassay-guided isolation of a Mycobacterium tuberculosis bioflim inhibitor from Arisaema sinii Krause.
Jiang CH; Gan ML; An TT; Yang ZC
Microb Pathog; 2019 Jan; 126():351-356. PubMed ID: 30471433
[TBL] [Abstract][Full Text] [Related]
10. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria.
Ojha AK; Baughn AD; Sambandan D; Hsu T; Trivelli X; Guerardel Y; Alahari A; Kremer L; Jacobs WR; Hatfull GF
Mol Microbiol; 2008 Jul; 69(1):164-74. PubMed ID: 18466296
[TBL] [Abstract][Full Text] [Related]
11. Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms.
Islam MS; Richards JP; Ojha AK
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):1055-66. PubMed ID: 23106280
[TBL] [Abstract][Full Text] [Related]
12. Effects of CwlM on autolysis and biofilm formation in Mycobacterium tuberculosis and Mycobacterium smegmatis.
Wang C; Zhang Q; Tang X; An Y; Li S; Xu H; Li Y; Wang X; Luan W; Wang Y; Liu M; Yu L
Int J Med Microbiol; 2019 Jan; 309(1):73-83. PubMed ID: 30563740
[TBL] [Abstract][Full Text] [Related]
13. Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis.
Chakraborty P; Bajeli S; Kaushal D; Radotra BD; Kumar A
Nat Commun; 2021 Mar; 12(1):1606. PubMed ID: 33707445
[TBL] [Abstract][Full Text] [Related]
14. Growth of Mycobacterium tuberculosis biofilms.
Kulka K; Hatfull G; Ojha AK
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371116
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
16. Drug susceptibility testing of mature Mycobacterium tuberculosis H37Ra and Mycobacterium smegmatis biofilms with calorimetry and laser spectroscopy.
Solokhina A; Bonkat G; Kulchavenya E; Braissant O
Tuberculosis (Edinb); 2018 Dec; 113():91-98. PubMed ID: 30514518
[TBL] [Abstract][Full Text] [Related]
17. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain.
Jeon AB; Ackart DF; Li W; Jackson M; Melander RJ; Melander C; Abramovitch RB; Chicco AJ; Basaraba RJ; Obregón-Henao A
Sci Rep; 2019 Feb; 9(1):1513. PubMed ID: 30728417
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl-prolyl isomerase-B is involved in
Kumar A; Alam A; Grover S; Pandey S; Tripathi D; Kumari M; Rani M; Singh A; Akhter Y; Ehtesham NZ; Hasnain SE
NPJ Biofilms Microbiomes; 2019; 5(1):3. PubMed ID: 30675370
[TBL] [Abstract][Full Text] [Related]
19. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
